ALUNBRIG® (brigatinib) Expert Opinion Video Series: Pill burden during treatment of ALK+ aNSCLC
Dr Yvonne Summers
Prescribing information is available at the top of the page.
Listen to Dr Yvonne Summers provide her opinion on pill burden and the convenience of once daily dosing during treatment with ALUNBRIG for ALK+ aNSCLC.
ALK+, anaplastic lymphoma kinase positive; aNSCLC, advanced non-small cell lung cancer.
To enjoy the full experience of OncoConnect, including the ability to like and bookmark content for easy access via your account section, please register or login now.
